Literature DB >> 29752261

NK-cell Editing Mediates Epithelial-to-Mesenchymal Transition via Phenotypic and Proteomic Changes in Melanoma Cell Lines.

Leticía Huergo-Zapico1, Monica Parodi1, Claudia Cantoni2,3,4, Chiara Lavarello5, Juan L Fernández-Martínez6, Andrea Petretto5, Enrique J DeAndrés-Galiana6, Mirna Balsamo2, Alejandro López-Soto7, Gabriella Pietra1,2, Mattia Bugatti8, Enrico Munari9, Marcella Marconi9, Maria Cristina Mingari1,2,3, William Vermi8,10, Lorenzo Moretta11, Segundo González7, Massimo Vitale12.   

Abstract

Tumor cell plasticity is a major obstacle for the cure of malignancies as it makes tumor cells highly adaptable to microenvironmental changes, enables their phenotype switching among different forms, and favors the generation of prometastatic tumor cell subsets. Phenotype switching toward more aggressive forms involves different functional, phenotypic, and morphologic changes, which are often related to the process known as epithelial-mesenchymal transition (EMT). In this study, we report natural killer (NK) cells may increase the malignancy of melanoma cells by inducing changes relevant to EMT and, more broadly, to phenotype switching from proliferative to invasive forms. In coculture, NK cells induced effects on tumor cells similar to those induced by EMT-promoting cytokines, including upregulation of stemness and EMT markers, morphologic transition, inhibition of proliferation, and increased capacity for Matrigel invasion. Most changes were dependent on the engagement of NKp30 or NKG2D and the release of cytokines including IFNγ and TNFα. Moreover, EMT induction also favored escape from NK-cell attack. Melanoma cells undergoing EMT either increased NK-protective HLA-I expression on their surface or downregulated several tumor-recognizing activating receptors on NK cells. Mass spectrometry-based proteomic analysis revealed in two different melanoma cell lines a partial overlap between proteomic profiles induced by NK cells or by EMT cytokines, indicating that various processes or pathways related to tumor progression are induced by exposure to NK cells.Significance: NK cells can induce prometastatic properties on melanoma cells that escape from killing, providing important clues to improve the efficacy of NK cells in innovative antitumor therapies. Cancer Res; 78(14); 3913-25. ©2018 AACR. ©2018 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29752261     DOI: 10.1158/0008-5472.CAN-17-1891

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  22 in total

Review 1.  Epithelial-Mesenchymal Plasticity in Tumor Immune Evasion.

Authors:  Riley D Z Mullins; Ananya Pal; Thomas F Barrett; Molly E Heft Neal; Sidharth V Puram
Journal:  Cancer Res       Date:  2022-07-05       Impact factor: 13.312

Review 2.  Human NK cells: surface receptors, inhibitory checkpoints, and translational applications.

Authors:  Simona Sivori; Paola Vacca; Genny Del Zotto; Enrico Munari; Maria Cristina Mingari; Lorenzo Moretta
Journal:  Cell Mol Immunol       Date:  2019-02-18       Impact factor: 11.530

Review 3.  Phenotype plasticity as enabler of melanoma progression and therapy resistance.

Authors:  Imanol Arozarena; Claudia Wellbrock
Journal:  Nat Rev Cancer       Date:  2019-06-17       Impact factor: 60.716

Review 4.  Consequences of EMT-Driven Changes in the Immune Microenvironment of Breast Cancer and Therapeutic Response of Cancer Cells.

Authors:  Snahlata Singh; Rumela Chakrabarti
Journal:  J Clin Med       Date:  2019-05-09       Impact factor: 4.241

Review 5.  The Vicious Cross-Talk between Tumor Cells with an EMT Phenotype and Cells of the Immune System.

Authors:  Elisabetta Romeo; Carmelo Antonio Caserta; Cristiano Rumio; Fabrizio Marcucci
Journal:  Cells       Date:  2019-05-15       Impact factor: 6.600

6.  Human CAR NK Cells: A New Non-viral Method Allowing High Efficient Transfection and Strong Tumor Cell Killing.

Authors:  Tiziano Ingegnere; Francesca Romana Mariotti; Andrea Pelosi; Concetta Quintarelli; Biagio De Angelis; Nicola Tumino; Francesca Besi; Claudia Cantoni; Franco Locatelli; Paola Vacca; Lorenzo Moretta
Journal:  Front Immunol       Date:  2019-04-30       Impact factor: 7.561

Review 7.  NKp44-NKp44 Ligand Interactions in the Regulation of Natural Killer Cells and Other Innate Lymphoid Cells in Humans.

Authors:  Monica Parodi; Herman Favoreel; Giovanni Candiano; Silvia Gaggero; Simona Sivori; Maria Cristina Mingari; Lorenzo Moretta; Massimo Vitale; Claudia Cantoni
Journal:  Front Immunol       Date:  2019-04-09       Impact factor: 7.561

Review 8.  An Historical Overview: The Discovery of How NK Cells Can Kill Enemies, Recruit Defense Troops, and More.

Authors:  Massimo Vitale; Claudia Cantoni; Mariella Della Chiesa; Guido Ferlazzo; Simona Carlomagno; Daniela Pende; Michela Falco; Annamaria Pessino; Letizia Muccio; Andrea De Maria; Emanuela Marcenaro; Lorenzo Moretta; Simona Sivori
Journal:  Front Immunol       Date:  2019-06-19       Impact factor: 7.561

Review 9.  The Adverse Impact of Tumor Microenvironment on NK-Cell.

Authors:  Ziming Hu; Xiuxiu Xu; Haiming Wei
Journal:  Front Immunol       Date:  2021-06-11       Impact factor: 7.561

Review 10.  Role of Hypoxic Stress in Regulating Tumor Immunogenicity, Resistance and Plasticity.

Authors:  Stéphane Terry; Rania Faouzi Zaarour; Goutham Hassan Venkatesh; Amirtharaj Francis; Walid El-Sayed; Stéphanie Buart; Pamela Bravo; Jérome Thiery; Salem Chouaib
Journal:  Int J Mol Sci       Date:  2018-10-06       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.